Mitochondrial proteomic profiling reveals increased CA II in aging and neurodegeneration, suggesting that targeting CA II associated with mitochondria could specifically modulate age-related impairments and neurological diseases [92]. The gene discussed is CA2; the disease is nervous system disorder.